Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Syndax Pharmaceuticals stock

Learn how to easily invest in Syndax Pharmaceuticals stock.

Syndax Pharmaceuticals Inc is a biotechnology business based in the US. Syndax Pharmaceuticals shares (SNDX) are listed on the NASDAQ and all prices are listed in US Dollars. Syndax Pharmaceuticals employs 59 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Syndax Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SNDX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Syndax Pharmaceuticals stock price (NASDAQ: SNDX)

Use our graph to track the performance of SNDX stocks over time.

Syndax Pharmaceuticals shares at a glance

Information last updated 2022-06-24.
Latest market close$19.07
52-week range$13.27 - $22.71
50-day moving average $16.17
200-day moving average $17.43
Wall St. target price$31.29
PE ratio 69.6715
Dividend yield $0 (0%)
Earnings per share (TTM) $0.27

Buy Syndax Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Syndax Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Syndax Pharmaceuticals price performance over time

Historical closes compared with the close of $19.07 from 2022-07-01

1 week (2022-06-24) -0.31%
1 month (2022-06-02) 14.88%
3 months (2022-04-01) 8.23%
6 months (2021-12-31) -12.88%
1 year (2021-07-02) 8.41%
2 years (2020-07-02) 30.80%
3 years (2019-07-02) 111.18%
5 years (2017-06-30) 36.51%

Is Syndax Pharmaceuticals stock undervalued or overvalued?

Valuing Syndax Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Syndax Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Syndax Pharmaceuticals's P/E ratio

Syndax Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 70x. In other words, Syndax Pharmaceuticals shares trade at around 70x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Syndax Pharmaceuticals's EBITDA

Syndax Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $16.6 million.

The EBITDA is a measure of a Syndax Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Syndax Pharmaceuticals financials

Revenue TTM $139.3 million
Operating margin TTM 11.86%
Gross profit TTM $139.7 million
Return on assets TTM 2.94%
Return on equity TTM 5.14%
Profit margin 11.11%
Book value $6.81
Market capitalisation $1.1 billion

TTM: trailing 12 months

Syndax Pharmaceuticals share dividends

We're not expecting Syndax Pharmaceuticals to pay a dividend over the next 12 months.

Syndax Pharmaceuticals share price volatility

Over the last 12 months, Syndax Pharmaceuticals's shares have ranged in value from as little as $13.27 up to $22.71. A popular way to gauge a stock's volatility is its "beta".

SNDX.US volatility(beta: 1.53)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Syndax Pharmaceuticals's is 1.5304. This would suggest that Syndax Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Syndax Pharmaceuticals overview

Syndax Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co. , Ltd. Syndax Pharmaceuticals, Inc.

Frequently asked questions

What percentage of Syndax Pharmaceuticals is owned by insiders or institutions?
Currently 5.902% of Syndax Pharmaceuticals shares are held by insiders and 101.847% by institutions.
How many people work for Syndax Pharmaceuticals?
Latest data suggests 59 work at Syndax Pharmaceuticals.
When does the fiscal year end for Syndax Pharmaceuticals?
Syndax Pharmaceuticals's fiscal year ends in December.
Where is Syndax Pharmaceuticals based?
Syndax Pharmaceuticals's address is: 35 Gatehouse Drive, Waltham, MA, United States, 02451
What is Syndax Pharmaceuticals's ISIN number?
Syndax Pharmaceuticals's international securities identification number is: US87164F1057
What is Syndax Pharmaceuticals's CUSIP number?
Syndax Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 87164F105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site